You have no items in your shopping cart.
Description
Research Area
Images & Validation
−| Tested Applications | ELISA, FC, WB |
|---|---|
| Dilution Range | ELISA: 1:10,000 to 1:100,000, FC: 1:100, WB: 1:2,000 |
| Reactivity | Human |
| Application Notes |
Key Properties
−| Antibody Type | Primary Antibody |
|---|---|
| Host | Other |
| Clonality | Recombinant |
| Isotype | IgG Fab |
| Clone No. | Abz518 |
| Source/Expression System | E. coli |
| Purity | Humanized Recombinant HER2 Fab fragment was expressed in E. coli cells. The purity was estimated to be > 90% by SDS-PAGE analysis. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store vial at 2-8° C. Dilute only prior to immediate use. |
|---|---|
| Form/Appearance | Liquid (sterile filtered) |
| Buffer/Preservatives | 0.01% (w/v) Sodium Azide |
| Concentration | 0.59 mg/ml |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

ELISA results show the sensitivity of Humanized Recombinant Anti-human HER2 Fab fragment Antibody tested against purified HER2 protein. Each well was coated in duplicate with 1.0 µg of HER2. The starting dilution of antibody was 5.0 µg/ml.

Flow Cytometry of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Primary Antibody: Recombinant Anti-HER2 Fab fragment (red line) recognizes HER2 on SK-OV-3 cells while using Anti-human kappa FITC secondary antibody at 0.2 µl with a 56.8% positive cells. Controls used: (black line) no primary antibody, no secondary antibody, 0.6%; (green line) no primary antibody, Anti-human kappa FITC secondary antibody at 0.2 µl, 1.0%.

SDS-PAGE of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1: Molecular Weight Ladder. Lane 2: reduced recombinant HER2 Fab fragment. Lane 3: non-reduced recombinant HER2 Fab fragment.

Western Blot of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1 and 8: Molecular Weight Marker. Lane 2 and 6: 0.02 µg HER2. Lane 3 and 7: 20 µg non-spiked SKOV-3 lysate. Lane 4 and 9: 20 µg SKOV-3 lysate spiked with 0.05 µg HER2. Lane 5 and 10: 20 µg SKOV-3 lysate spiked with 0.02 µg HER2. Primary Antibody: Anti-HER2 Fab incubated with lanes 1-5 only. Secondatry Antibody: Anti-F(ab)'2 HRP conjugate at 1:5000. Anti-HER2 Fab antibody observed in native HER2 and spiked HER2 in SKOV-3 cell lysates.

Western Blot of Humanized Recombinant Anti-human HER2 Fab fragment Antibody. Lane 1: Molecular Weight Ladder. Lane 2, 5, and 8: Empty. Lane 3, 6, and 9: HER2 reduced. Lane 4, 7, 10: HER2 non-reduced. Protein Load: Lane 3-4: 0.5 µg. Lane 6-7: 0.1 µg. Lane 9-10: 0.02 µg. Primary Antibody: anti-HER2 Fab at 1:2000 for 2 hours at 4°C. Secondary Antibody: Anti-human kappa FITC conjugate at 1:1000 for 2 hours at 4°C. Exposure time 60s.
Quick Database Links
UniProt Details
−NCBI Reference Sequences
−| Protein | NP_001005862.1 |
|---|
Documents Download
Request a Document
Protocol Information
Recombinant Anti-HER2 Fab Antibody (orb420301)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review